Unique Plan Description: cefTRIAXone (Rocephin) IM 2,000 mg / lidocaine 1% MPF
Plan Selection Display: cefTRIAXone (Rocephin) IM 2,000 mg / lidocaine 1% MPF
PlanType: Medical                                 
Version: 1          
Begin Effective Date: 2022-06-13 10:24:17
End Effective Date: 2100-12-31 00:00:00
Last Updated Date: 2022-06-13 10:24:17
Available at all facilities: No

cefTRIAXone (Rocephin) IM 2,000 mg / lidocaine 1%
Medications
	Rocephin IM
		2,000 mg, Injection, IM-IntraMUSCULAR, Once, STAT
			Comment: 2,000 mg cefTRIAXone vial dissolved with 4.2 mL yields 2,000 mg/5.72 mL final volume. Volume should be split into multiple syringes and given through multiple injection sites.
	Xylocaine-MPF 1% preservative-free injectable solution
		4.2 mL, Injection, IM-Intramuscular, Once, STAT
			Comment: 2,000 mg cefTRIAXone vial dissolved with 4.2 mL yields 2,000 mg/5.72 mL final volume. Volume should be split into multiple syringes and given through multiple injection sites.

*Report Legend:
DEF - This order sentence is the default for the selected order
GOAL - This component is a goal
IND - This component is an indicator
INT - This component is an intervention
IVS - This component is an IV Set
NOTE - This component is a note
Rx - This component is a prescription
SUB - This component is a sub phase